Ohya, S., Matsui, M., & Kajikuri, J. (2020). Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases, 29(4), 487–489. https://doi.org/10.15403/jgld-3234